Becky Quick is co-anchor of "Squawk Box" (M-F, 6AM-9AM ET). Quick is also anchor of the nationally syndicated "On the Money."
Quick is known for her hard-hitting interviews and profiles of some of the world's richest and most influential investors, including Warren Buffett, Bill Gates, Alan Greenspan, T. Boone Pickens, Jamie Dimon, Charlie Munger and many others. She also has interviewed three U.S. presidents and has hosted panels at some of the most prestigious conferences in the world such as the Microsoft CEO Conference, Fortune's Most Powerful Women's Conference and the Allen & Co. Sun Valley Media Conference. Quick also authors a regular column for Fortune magazine as well as contributes to CNBC.com.
Previously, Quick, a seven-year veteran of The Wall Street Journal, covered the Wall Street beat for CNBC as part of the network's partnership with Dow Jones.
Prior to joining CNBC in February 2001, Quick covered various beats for The Wall Street Journal, including retail, e-commerce and the Internet. She also played a crucial role in the launch of The Wall Street Journal Online, while serving as the site's International news editor.
She graduated from Rutgers University in New Brunswick, N.J., and previously served on the board of The Robert Wood Johnson University Hospital.
Follow Becky Quick on Twitter @BeckyQuick
CNBC's Becky Quick speaks with Warren Buffett about why he abstained from voting on Coca-Cola's executive-compensation plan and responds to activist investor David Winters criticism. "We didn't disapprove of management, but we did disapprove of the plan," Buffett said.
CNBC's Becky Quick discusses Warren Buffett's feelings about Coke, IBM and his general sentiment about the market.
The Fed has a "small window to start normalizing," and "they intend to take advantage of it," Mohamed El-Erian tells CNBC.
We're still a long ways off from achieving peace in the Middle East, retired Adm. James Stavridis says.
Markets still haven't given the Fed a green light to keep tightening, Jurrien Timmer of Fidelity Investments says.
Bayer says it has offered $122 per share for Monsanto in an all-cash deal that values the U.S. company at $62 billion.
Get the best of CNBC in your inbox